ArticleBlood2008

Phase 1 study of the oral isotype specific histone deacetylase inhibitor MGCD0103 in leukemia.

Guillermo Garcia-Manero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.